CytRx brain cancer drug shows promise in trial, shares rise

January 6, 2015 3:35 PM

5 0

(Reuters) - CytRx Corp said interim data showed its experimental brain cancer drug was effective in preventing the progression of tumors and even shrunk them.

The company's shares rose up as much as 30 percent and were among the top percentage gainers and the most actively traded on the Nasdaq.

Also read: Private equity firm Northstar to buy Singapore-listed Innovalues for $239 mln

Read more

To category page